Merck & Co Inc (LTS:0QAH)
$ 131.3 0 (0%) Market Cap: 249.37 Bil Enterprise Value: 272.91 Bil PE Ratio: 20.67 PB Ratio: 5.61 GF Score: 81/100

Merck & Co Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript

Dec 02, 2020 / 02:40PM GMT
Release Date Price: $78.8
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research

Okay. Excellent. Well, listen, guys, thank you all for joining us. It's a pleasure to have Rob as well as Peter join us. Peter is here in spirit and also on the phone and Rob's there live. Jon and I will be hosting Merck. So thank you for joining us.

And before we dig into all our random questions, Rob, let me first turn it over to you to highlight what's on top of your mind and the key priorities for you as we head into the new year?

Robert M. Davis
Merck & Co., Inc. - Executive VP of Global Services & CFO

Sure. Well, thank you, Umer, and thank you for having us. What I would just leave you with is maybe some opening thoughts. Coming out of the third quarter and as we look to the full year of 2020 and based on the guidance we give we gave at the third quarter, I think it really shows the operational underlying strength of our business. If you look at it, the guidance we provided would imply our top line growth, if you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot